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INTRODUCTION 
Khalvi Rasayana (drugs prepared using morter and 
pestel) is one amongst the novel drug design 
Protocols. It is an applied Pharmaceutical method of 
Phytometalo-mineral Pharma product preparations, 
without much disturbance to the Phytominerallo 
metallic ingredients used in the preparation, 
ecobiological    acceptable    nanotech    particles    are 
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brought out in physiologically acceptable bondage 
patterns. Hence their safety, activity, cost effective 
utility are understood. Kapha Ketu Rasa is one such 
molecule in which Shanka Bhasma (incinerated conch 
shell), Shodita Tankana (purified borax), Shodita and 
Vastragalita Vatsanabha (purified fine powder of 
Aconitum ferox) and Pippali choorna (powder of Piper 
longum) are homogenously mixed and Bhavana 
(trituration) given with Ardraka Swarasa (juce of 
Zingeber officinalis) for 3 times.
[1]
 
The Clinical practitioners are convinced today about, 
co-existence and complementary collaborative 
presentations of GERD and Bronchial asthma.  
Treating GERD along with the treatment of bronchial 
asthma will enhance the clinical success rate. 
Therefore modern medical practitioner will prescribe 
a co-drug acting on GERD along with the prescription 
for bronchial asthma to get good results. 
At this juncture, it is worth to notice the 
pharmacology of Kapha Ketu Rasa in the same 
perspective.  This product is essentially composed of 
A B S T R A C T  
Context: Compound drugs are scientifically formulated aiming to get the desired therapeutic effects 
through synergy. Kapha Ketu Rasa is one such compound drug which is a classical herbo mineral 
marine Khalvi Rasayana  judicially containing Shankha Bhasma, Vatsanabha, Tankana and Pippali. 
Treating GERD along with the treatment of bronchial asthma will enhance the clinical success rate.  At 
this juncture, it is worth to notice the pharmacology of Kapha Ketu Rasa in the same perspective. 
Aims: To study the clinical effect of Kapha Ketu Rasa on Tamaka Swasa (Bronchial asthma). 
Materials and Methods: 30 Patients of Tamaka Swasa  irrespective of age, sex, religion etc., were 
randomly selected and treated with 125 mg of Kapha Ketu Rasa capsules twice a day with Ardraka 
Swarasa before meals for 21 days, then followed for 21 more days. Results: The clinical study 
showed statistically highly significant improvement in both subjective and objective parameters viz. 
Kasa (91%), Ghurghurata (83%) and Swasakruchrata (82%) including decrease in AEC, ESR, 
Differential eosinophil count and PEF was also statistically significantly improved. Conclusions: Kapha 
Ketu Rasa is an effective Vyadhi Pratyanika herbo mineral Shamana Rasayana in the management of 
Tamaka Swasa. 
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drugs acting on GERD (Shankha Bhasma) and drugs 
effective in respiratory congestion and broncho 
constriction (Pippali, Tankana, Vatsanabha). As the 
clinical condition Tamaka Swasa (Bronchial asthma) is 
acute  and life threatening at that moment.
[2]
 A fast 
acting, centrally effective drug is required hence very 
fast acting and more powerful drug Vatsanabha is 
logically present in Kapha Ketu Rasa. 
The ultimate aim of any drug researches is 
appropriate management of the particular disease 
and promote and positive health based on the 
methodology prevalent in ancient times. Ayurvedic 
therapeutic measures and procedures have remained 
in practice since a long time. Due to this fact, clinical 
therapeutic trails are of paramount importance to 
prove the rationality of Ayurvedic therapeutic 
approach on scientific lines. So, in the present study a 
clinical trial of Kapha Ketu Rasa on Tamaka Swasa is 
designed, experimented with the aim of answering 
some precisely framed questions conducted on 
scientific lines.  
As there was no established clinical data on Kapha 
Ketu Rasa in the management of Swasa Roga and as a 
part of phase wise clinical study, a short pilot study on 
Kapha Ketu Rasa was required to ensure the optimum 
dose tolerance and clinical untoward effects if any. 
Hence, before the clinical study proper, a pilot clinical 
study was conducted and depending upon the 
outcome of pilot study, the clinical study was carried 
out. To get more documentary evidences, updating of 
the knowledge and to get more scientifically 
confidence in ancient Indian Health tradition, the 
present study was carried out. 
OBJECTIVES 
1. To carry out a pilot clinical trial of Kapha Ketu 
Rasa on Tamaka Swasa. 
2. To evaluate the clinical effect of Kapha Ketu Rasa 
on Tamaka Swasa. 
MATERIALS AND METHODS 
Selection of Patients 
For both  pilot and clinical study proper, patients 
complaining of Kasa (cough), Ghurguratha (wheezing) 
and Swasakruchrata (dyspnoea) were randomly 
selected irrespective of age, sex, religion etc., from 
OPD and IPD of Taranath Govt. Ayurvedic Medical 
college, and Hospital, Bellary, Bellary. These patients 
were selected as per criteria vide below. 
Inclusion criteria  
1. Classical symptoms of Tamaka Swasa  like cough, 
wheezing and dyspnoea etc., 
2. Already diagnosed and under treatment cases of 
Tamaka Swasa. 
Exclusion criteria 
1. Patients suffering from Mahaswasa, Urdwaswasa, 
Chinnaswasa etc., 
2. Patients suffering from Asadhya Lakshanas 
(incurable symptoms) of Tamaka Swasa and other 
systemic desirous illnesses like Hydro-pneumo-
pyo-haemo-thorax, pneumonia,  pulmonary 
tuberculosis, IHD, IDV, RHD etc., 
3. Garbhini (pregnant), Prasoota (post partum 
women), Ksheerapa (lactating women), Vruddha 
(aged above 60yr) etc., 
Sampling   
By adopting systemic random sampling method, 
Kapha Ketu Rasa was administered for patients of 
pilot study and also later on patients trial proper of 
Tamaka Swasa. 
Posology 
 Dosage : 125 mg 3-4 times  a day  
 Form : Soft gelatin capsule of 125 mg. 
 Duration : upto 21 days. 
 Follow up : 21 days  
 Anupana : Ardraka Swarasa 
 Aushadhi Sevanakala : Before meals  
Table 1: Criteria for assessment grading for 
subjective parameter  
SN Symptoms Severity Attacks Grade 
1 Kasa  
(Cough) 
No 
Mild 
- 
0-5 
0 
1 
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Moderate 
Severe 
6-10 
>11 
2 
3 
2 Swasakruchrata 
(dyspnoea)  
No 
Mild 
Moderate 
Severe 
- 
0-3 
4-6 
>6 
0 
1 
2 
3 
3 Ghurghurata 
(wheezing) 
No 
complaints 
Mild 
Moderate 
Severe 
- 
0-3 
4-6 
>6 
0 
1 
2 
3 
Objective parameter  
Hb%, TLC, DLC, ESR, RBS, Urine; Sugar, Albumin, 
Microscopy, PEF. 
Treatment: was assessed as very good improvement, 
good improvement, moderate improvement, mild 
improvement and no improvement. 
1. Very good improvement - 75% or above relief in 
signs and symptoms. 
2. Good improvement  - 51 to 75% of signs and 
symptoms were relieved. 
3. Moderate improvement - 26 to 50% of signs and 
symptoms were relieved. 
4. Mild improvement -  1-25% of signs and 
symptoms were relieved. 
5. No improvement - No improvement in signs and 
symptoms were considered.  
OBSERVATIONS AND RESULTS 
Demographic data of 10 patients of pilot study  
Table 2: Age wise distribution     
Age (Yrs) No. of Patients Percentage 
< 20 1 10% 
21-30 0 0% 
31-40 5 50% 
41-50 2 20% 
> 50 2 20% 
Total 10 100% 
  
Table 3: Sex wise distribution 
Sex No. of Patients Percentage 
Male 6 60 
Female 4 40% 
Total 10 100% 
Table 4: Occupation wise distribution   
Occupation No. of Patients Percentage 
Labour  3 30% 
Housewives 4 40% 
Student  1 10% 
Office 2 20% 
Total  10 100% 
 
Table 5: Chronicity  wise distribution 
Chronicity  No. of Patients Percentage 
< 1 year 1 10% 
1-5 years 5 50% 
6-10 years 3 30% 
>10 years 1 10% 
Total  10 100% 
Table 6: Prakriti wise distribution        
Prakriti No. of Patients Percentage 
Kapha Pitta  2 20% 
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Vata Kapha 1 10% 
Kapha Vata 4 40% 
Pitta Kapha 1 10% 
Vata Pitta 2 20% 
Total  10 100% 
 
Table 7: Diet wise distribution 
Diet  No. of Patients Percentage 
Vegetarians  4 40% 
Mixed  6 60% 
Total  10 100% 
 
RESULTS OF PILOT STUDY  
Table 8: Effect of Kapha Ketu Rasa on Tamaka Swasa 
Parameters N 
Mean 
score (d) Mean  
difference 
% of 
relief 
BT AT 
Swasa 
Kruchrata 
10 2.9 0.4 2.5 ↓86.2% 
Kasa 10 1.9 0.1 1.8 
↓ 
95.2% 
Ghurghurata 10 2.3 0.3 2.0 
↓ 
86.9% 
 
Observations of clinical study proper 
It was an observational clinical study. 35 patients 
were incidentally selected and randomly treated after 
informed consent with 125 mg of Kapha Ketu Rasa 
capsules twice a day with Ardraka swarasa before 
meals for 21 days, then followed for 21 more days. 
Out of 35 patients, 5 patients did not complete the 
course, hence the demographic data of 35 patients 
was tabulated and the clinical results of 30 completed 
patients was statistically tabulated and analysed. 
Demographic data of 35 patients of Tamaka Swasa  
Table 9: Age wise distribution  
Age  No. of Patients Percentage 
<20 6 17.14% 
21-30 6 17.14% 
31.40 8 22.85% 
41-50 10 28.57% 
>50 5 14.28% 
 
Table 10:   Sex wise distribution 
Sex No. of Patients Percentage 
Male 24 68.57% 
Female 11 31.42% 
 
Table 11: Religion wise distribution 
Religion No. of Patients Percentage 
Hindu 30 57.71% 
Muslim 5 14.28% 
 
Table 12: Occupation wise distribution 
Occupation No. of Patients Percentage 
Labour  8 22.85% 
Housewives  8 22.85% 
Business 7 20% 
Student  6 17.14% 
Office  6 17.14% 
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Table 13:  Chronicity wise distribution 
Chronicity  No. of Patients Percentage 
< 1 Year 9 25.71% 
1-5 years 17 48.57% 
6-10 years 4 11.42% 
> 10 years 5 14.28% 
 
Table 14:   Socio-economic status wise distribution 
Socio-economic 
status  
No. of Patients Percentage 
Rich 5 14.28% 
Middle class 20 57.14% 
Poor 10 28.57% 
Table 15: Family History wise distribution 
Family History No. of Patients Percentage 
Yes 19 54.28% 
No 16 45.71% 
Table 16: Seasonwise distribution 
Season No. of Patients Percentage 
Cold 22 62.85% 
All 13 37.14% 
Table 17: Sleep  wise distribution 
Sleep No. of Patients % 
Disturbed  20 57.14% 
Sound  15 42.85% 
 
Table 18:  Prakriti wise distribution 
Prakriti No. of Patients Percentage 
Kapha Pitta 14 40% 
Kapha Vata 11 31.42% 
Vata Pitta 10 28.57% 
Table 19: Diet wise distribution 
Diet  No. of Patients Percentage 
Mixed  27 77.14% 
Vegeterian  8 22.85% 
Table 20: Exposure to Dust wise distribution 
Exposure to Dust No. of Patients Percentage 
Yes 23 65.71% 
No 12 34.28% 
 
RESULTS 
Table 21: Effect of Kapha Ketu Rasa on 30 patients of Tamaka Swasa 
Parameter n  
Mean score  
Mean 
difference 
% of 
relief 
SD + SE + t P 
95% 
confidence 
limit BT AT/AFU 
Swasa 
Kruchrata 
30 
BT & 
AT 
2.63 0.47 2.16 82%↓ 0.5312 0.097 22.375 P<0.001 1.97 to 
2.36 
BT & 
AFU 
2.53 0.53 2.00 79%↓ 0.6627 0.121 17.357 P<0.001 1.85 to 
2.35 
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Kasa 30 
BT & 
AT 
2.53 0.23 2.30 91%↓ 0.6408 0.117 17.095 P<0.001 1.76 to 
2.24 
BT & 
AFU 
2.53 0.37 2.16 85%↓ 0.6682 0.122 16.148 P<0.001 1.72 to 
2.22 
Ghurghurata 30 
BT & 
AT 
2.4 0.4 2.00 83%↓ 0.5970 0.109 21.102 P<0.001 2.08 to 
2.52 
BT & 
AFU 
2.4 0.43 1.97 82%↓ 0.6463 0.118 18.39 P<0.001 1.92 to 
2.41 
 
Table 22: Effect of Kapha Ketu Rasa on 30 patients of Tamaka Swasa 
Para 
meter 
n  
Mean score Mean 
difference 
% of 
relief 
SD + SE + t P 
BT AT/ AFU 
AEC 30 
BT & 
AT 
461.3 344.03 117.27 25.4%↓ 157.04 28.672 4.322 P<0.001 
BT & 
AFU 
461.3 356.33 104.97 22.8%↓ 140.9612 25.736 4.364 P<0.001 
ESR 30 
BT & 
AT 
20.9 15.03 5.87 28.1%↓ 5.7401 1.048 5.601 P<0.001 
BT & 
AFU 
20.9 15.43 5.47 27.2%↓ 6.3340 1.1564 4.727 P<0.001 
PEF 30 
BT & 
AT 
223.17 311.5 88.33 39.6%↑ 58.4916 10.6794 7.335 P<0.001 
BT & 
AFU 
223.17 313.17 90 40.3%↑ 61.42 11.2137 7.134 P<0.001 
 
Table 23:  Effect of Kapha Ketu Rasa on 30 patients of Tamaka Swasa 
Para meter 
n  
d Mean 
difference 
SD + SE + t p 
Statistical 
significant 
Hb% 
30 
BT & AT 0.1267 0.3070 0.056 2.258   
P< 0.05 
Significant  
BT & AFU 0.19 0.4147 0.757 2.510 P < 0.05 Significant  
TLC 
30 
BT & AT 136.6667 413.3407 75.466 1.811 P=0.081 Not significant 
BT & AFU 86.6667 346.3936 63.243 1.370 P=0.181 Not significant 
RBS 
30 
BT & AT 2.1333 6.7248 1.228 1.738 P=0.093 Not significant 
BT & AFU 0.333 10.7906 1.97 0.169 P=0.867 Not significant 
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DLC 
L 30 
BT & AT 0.9333 2.6514 0.484 1.928 P=0.064 Not significant 
BT & AFU 1.2 2.8454 0.519 2.310 P <0.05 Significant  
E 30 
BT & AT 2.5667 2.2542 0.412 6.236 P <0.001 Highly significant  
BT & AFU 2.5 2.2245 0.406 6.156 P <0.001 Highly significant  
P 30 
BT & AT 0.8387 2.77 0.5057 1.686 P>0.05 Not significant 
BT & AFU 0.4667 3.1154 0.5688 0.820 P = 419 Not significant 
M 30 
BT & AT 0.1364 0.9902 0.1808 0.646 P=525 Not significant 
BT & AFU 0.0476 1.0713 0.1956 0.204 P = 841 Not significant 
DISCUSSION 
Clinical effect of Kapha Ketu Rasa on Tamaka swasa 
was carried out supported by  pilot studies. Details of 
Kapha Ketu Rasa was critically understood and then it 
was validated with present prospective single blind 
open observational study. It may be inferred that the 
ancient and current pharmacological properties of 
Kapha Ketu Rasa are very near to Chikitsa (treatment) 
principles. This message of the basic principles of drug 
designing in Rasashastra are well balanced with 
Chikitsa principle of Ayurveda. This reality of 
integration is in its real sense of contribution to the 
novel drug discovery theories of Indian medical 
heritage.  
Discussion on pilot clinical study 
In the classical reference, exact dose of Kapha Ketu 
Rasa per day for swasa roga and duration were not 
mentioned. Hence to fix the dose and to confirm the 
safety profile of the drug, pilot study on 10 patients 
was carried out by incidental selection and 
randomisation. Kapha Ketu Rasa was administered in 
a dose of 125 mg thrice a day in capsule form along 
with Ardraka Swarasa before food for 21 days and the 
percentage of relief was calculated. None of the 
patients discontinued the therapy may be due to the 
experience of good relief. It was also observed that 
the action of the drug was showing positive 
improvement within 30-60 minutes of administration 
and the effect persists for 4-12 hours, with no gastric 
irritation or nausea. None of the patient complained 
tingling sensation, numbness, burning sensation, 
delirium and any other adverse effect after the 
consumption and even after the completion of 
treatment. The overall response and general feeling of 
well being were better after the use of Kapha Ketu 
Rasa. Therefore the pilot study inferred the safe and  
 
clinicaly effective use of Kapha Ketu Rasa at the 
prescribed dose and duration. As there was no 
apparent requirement of any modern emergency 
medicine during the treatment, the pilot study gave 
the moral clinical support without the assistance of 
modern bronchodilator, antihistamines or antitussive. 
Hence clinical study proper was conducted as 
designed.  
Discussion on clinical study proper 
Clinical research is ultimate part of the bio-medical 
research. The quest for suitable remedy for Tamaka 
Swasa dates back to even vedic period. The 
encouraging outcome of pilot clinical study helped to 
the successful completion of clinical trial. Traid of 
symptoms were considered, baseline safety profiles 
along with peak expiratory flow was an objective 
parameter. Subjective symptoms and overall response 
were assessed based on specially designed scoring 
pattern and as a part of departmental contribution 
and in the view of Ayurvedic – Rasashastra drug 
research protocol, the Karmukata (action) of Kapha 
Ketu Rasa was also tried to assess based on the 
classical Guna (properties), Karma (action) and 
applied Bheshaja (medicinal) Karma theories. The 
clinical study was planned in such a way to evaluate 
the drug effect in majority including the aetio 
pathological and demographic understanding and 
echo social impact after the ethical clearance.  
Discussion on observations 
In the present study, demographically it was observed 
that maximum (28.57%) patients belonged to 41-50 
year age group, immediately followed with 22.85% of 
31-40 years age group, may be due to more stress and 
strain and as this age group people were of working 
classes and housewives, more exposed to dust, fumes, 
smoke, pollens etc. Most (68.57%) of them were 
males due to their dieting habits viz., consuming 
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unwholesome,  contaminated food etc. bad habits viz. 
smoking, alcohol etc. Maximum (85.71%) of patients 
were Hindus as the area where trial conducted was 
dominated by Hindu community. Majority (22.85% 
each) of patients were labours and housewives, may 
be due to more exposed to dust, fumes and smoke, 
patients having 1-5 years chronicity were reported in 
maximum (48.57%) may be due to the nature of the 
disease i.e. Yapya (manageable), reoccuring by the 
triggering factors like seasonal variations dust etc. 
Middle class people were more (57.14%) affected, 
may be due to their inability to afford for private 
consultation and purchase of costly medicine. 
Maximum (54.28%) patients had family history of 
Asthma which may be due to Bijadosha (genetic) 
producing Swasa or diet pattern etc. were also not 
withdrawn from their respective families and 
societies. Majority (62.85%) of patients were suffering 
in cold seasons it may be due to Kapha Prakopa 
(inceasing Kapha Dosha) Kala which had an impact on 
disease status and showed there was a strong 
influence of seasonal variation on disease status. 
Majority (57.14%) of patients had disturbed sleep, 
supporting to the symptoms of Tamaka Swasa, may 
be due to the severity of disease, made the patient 
restless. It was also observed that Kapha Pitta Prakruti 
patients were more (40%), followed by 31.42% 
belonged to Kapha Vata Prakruti. Mixed diet people 
were affected more (77.14%) may be due to 
predominance of life style modifications and also 
intake of Guru, Abhishyandi Ahara causing the 
disease. Majority (65.71%) of patients were exposed 
to dust, may be due to hygienic conditions of the 
concerned area and industries near the working place.  
Discussion on results 
Kapha Ketu Rasa is more significant in reducing the 
Kasa, followed by Ghurghurata and then by 
Swasakruchrata. Kapha Ketu Rasa is dominated with 
50% Katu Rasa (hot taste), hence it is predominant in 
Vayu and Agni mahabhoota which have the tendency 
to act with upward direction. As Kapha Ketu Rasa is 
Katurasa dominant, in case of Tamaka Swasa it acts 
as Shothahara (Anti inflammatory), Kandu Vinashana 
(Anti histamine), Krimin Hinasthi (Anti microbial), 
Margan Vivrunoti (Bronchodilator), Kleda, Kapha, 
Malanupahanti (eradicates excessive respiratory 
secretions, expectorant). Due to its Katu Rasa, Kapha 
Ketu Rasa combats the Phena Mala Kapha Utpatti 
(excessive secreation) in the Amashaya (stomach).
[3] 
Kapha Ketu Rasa possesses 12.5% of Madhura Rasa 
(sweet taste), hence drug is Balya (strengthening), 
Marma Paripalana Rasayana (rejuvenator which 
protects the vitals), Pittavata Hara (reduces Pitta and 
Vata Dosha)
[4] 
and helps in synergistic arrest of gastric 
irritation of the drug and GERD. 12.5% of Kashaya 
rasa (astringent taste) of Kapha Ketu Rasa helps in 
allievation of Kapha and Pitta Doshas of respiratory 
airway disorders and does Shoshana ( dries up the 
excessive secreation).
[5] 
Kapha Ketu Rasa also 
possesses 12.5% of Kshara Rasa(alkaline taste) hence 
drug dissolves and then eliminates Kapha Dosha etc.  
Kapha Ketu Rasa has 25% of Teekshna Guna 
(penentrative quality), Agni Mahabhoota dominance 
which is Kaphaghna
[6]
 (mucolytic – muco kinetic) and 
Shodhana (expectorant effect), are very essential 
pharmacological activities in treating Swasa Roga. 
Kapha Ketu Rasa has 18.75% each of Laghu Guna 
(lightness) and Rooksha Guna (dryness), therefore it 
acts as Kaphaghna (reduces phlegm), Leknana 
(scraping) and Ropana (healing)
[7] 
means by virtue of 
Laghu and Rooksha Guna, Kapha Ketu Rasa helps to 
clear the inflammation congestion present in airways. 
Hence effective in Swasa Roga. Vyavayi and Vikashi 
Guna accounts for (6.25% each) quick absorption and 
easy transportation of the drug into cell membrane. 
Kapha Ketu Rasa is neuro endocrino immunological 
stabilizer of respiratory system hence is a respiratory 
Rasayana most useful in all treatable cases of Swasa 
Roga. Duration of attacks are prolonged and positive 
health is promoted. 
It seems that 60% of Ushna Veerya (hot potency) of 
Kapha Ketu Rasa is more influencing the activity of 
drug. So Kapha Ketu Rasa is Pachana (digestive), 
Svedana (diaphoretic), Vilayana (liquification), and 
potent Vatakapha Shamaka
[8]
 i.e. eradicates and 
reverses the pathophysiology of Swasa Roga, mainly 
mucolytic and expectorant and also inhibit the 
excessive secretions and discharges even though 
Ushna Veerya, 20% Sheeta Veerya (cold potency) of 
Kapha Ketu Rasa make it synergistically balanced and 
unwanted effects of drug and target cell specific 
activity is augmented which is unique holistic nature 
of Kapha Ketu Rasa.  
Kapha Ketu Rasa is also analysed based on reverse 
pharmacology that it is Vatakapahahara (80%) and 
Kapahpittahara (20%), both these effects are as per 
the principles of Swasa chikitsa.
[9]
 The ingredients of 
Kapha Ketu Rasa have Deepana (digestive), Pachana, 
Swasaghna (anti asthmatic), Kasaghna (antitussive), 
Jwaraghna (febrifuge) and Rasayana (rejuvinative) 
properties. Katu – Kshara – Sheeta properties of 
Shanka Bhasma is effective in Pitta Kapha Shamana, 
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Amlapitta (gastritis) and Swasahara effect.
[10]
 It is a 
direct reference for the role of Shanka Bhasma in 
curing GERD and hence Tamaka Swasa. Shankha 
Bhasma is a good drug in GERD and GERD coexists and 
triggers the bronchial asthma.
[11]
 Hence the judicious 
combination of Shankha Bhasma Yukta Khalvi 
Rasayana is effective in Tamaka Swasa by virtue of its 
curative effect on GERD and hence Tamaka Swasa.  In 
total, Kapha Ketu Rasa synergistically a potent fast 
acting Khalvi Rasayana having Vatakaphara, 
Kaphapittahara, Tridoshahara, Vatanulomana 
(demulcent), Katu, Laghu, Teekshna, Rooksha, Ushna, 
Shothahara (anti inflammatory), Kanduhara, Sroto 
Shodhana (cleanses the channels), Vatanulomana, 
Marga Vivarana (bronchodilator), Deepana, Pachana, 
Jwaraghna, Krimighna (antihelmenthic), Balya, 
Bruhmana (nourishing), Vishahara (antidote) 
properties. Kasa Swasahara, Rasayana effect. Due to 
its Balya, Brumhana and Vatahara effect, it acts as 
Marmaposhaka drug. Hence Kapha Ketu Rasa is found 
to be a promising phyto mineral Khalvi Rasayana and 
pharmacology of it requires current updating.   
CONCLUSION 
The pilot observational clinical study of Kapha Ketu 
Rasa on Tamaka Swasa was encouraging and showed 
relief in Kasa (95.2%), Ghurghurata (86.9%) and 
Swasakruchrata (86.2%) and drug intolerance, gastric 
irrition and other adverse effects were not observed. 
The clinical study proper showed statistically highly 
significant improvement in both subjective and 
objective parameters viz. Kasa (91%), Ghurghurata 
(83%) and Swasakruchrata (82%) including decrease 
in AEC, ESR, Differential eosinophil count and PEF was 
also statistically significantly improved. Kapha Ketu 
Rasa is an effective Vyadhi Pratyanika phyto steroidal 
mineral Shamana Rasayana in the management of 
Tamaka Swasa.  None of the patients show any 
untoward effects during the study period. 
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